Latest Revenue Guidance News

Page 3 of 30
Jack Henry delivered a stronger-than-expected fiscal first quarter, with revenue, operating income and earnings per share all accelerating year on year. Cloud, card, digital and faster-payments demand supported the result, while buybacks and higher borrowings shaped the capital picture.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Arista Networks delivered third-quarter revenue well above its own guidance, with sales reaching US$3.66 billion and GAAP net income hitting US$1.56 billion. The networking specialist is now guiding to as much as US$4.0 billion in fourth-quarter revenue as it expands its AI infrastructure portfolio.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Waters delivered a stronger-than-expected third quarter, lifting every component of its 2026 guidance while organic growth accelerated across instruments, consumables and reagents. The company also acquired MOBILion Systems to extend its mass spectrometry technology into proteomics.
Sophie Babbage
Sophie Babbage
4 Nov 2026
Pfizer has lifted its 2026 revenue and adjusted earnings guidance after a quarter in which newer and acquired medicines grew strongly enough to offset steep declines in COVID-19 products. Overall revenue was flat, while reported net income fell 8%.
Victor Sage
Victor Sage
4 Nov 2026
Palantir delivered a record fiscal third quarter, with revenue rising 96% to US$2.313 billion and US commercial revenue overtaking government revenue for the first time. The company also lifted its full-year 2026 guidance across revenue, commercial sales and cash flow.
Sophie Babbage
Sophie Babbage
3 Nov 2026
Vertex has raised its full-year 2026 revenue guidance after third-quarter sales climbed 12%, but the Crinetics acquisition sharply increased costs and debt. The next major test arrives on 30 November, when US regulators are due to rule on povetacicept for IgA nephropathy.
Ada Torres
Ada Torres
3 Nov 2026
IDEXX Laboratories has raised its 2026 revenue and earnings outlook after reporting 10% third-quarter revenue growth and an 18% rise in diluted EPS. The upgrade came alongside rapid adoption of its inVue Dx analyzers, although acquisition costs prompted a lower full-year operating margin forecast.
Ada Torres
Ada Torres
2 Nov 2026
Volt Group has lowered its FY26 revenue and EBITDA guidance after weaker-than-expected EcoQuip sales, despite reporting stronger year-to-date operating cashflow and solid growth from 4D Delta. The company is committing $3.0 million to expand and refurbish its mobile solar-lighting fleet as it tries to convert customer trials into revenue.
Victor Sage
Victor Sage
2 Nov 2026
Osteopore reported record quarterly revenue of A$859,000 in Q3 CY26 as it added market access in Thailand and Saudi Arabia and completed its first customised Hainan implant. The regenerative implant maker remains cash-flow negative, with A$712,000 in cash and A$14 million still available under its convertible note facility.
Victor Sage
Victor Sage
30 Oct 2026
Horseshoe Metals is consolidating high-grade material at Horseshoe Lights for potential 500-tonne DSO sales in the December quarter, while new exploration work points to a much larger copper system. The opportunity comes with important qualifiers: offtake proposals remain non-binding, the exploration target is conceptual and cash on hand was just $31,000.
Maxwell Dee
Maxwell Dee
30 Oct 2026
WhiteHawk reported a US$313,000 operating cash outflow for the September quarter, while a new A$1.5 million debt facility and A$1.24 million in annualised cost savings support its next phase. The post-quarter completion of Quixxi adds AI governance products, international customers and a four-year A$635,238 Italian contract, but revenue conversion remains the test.
Victor Sage
Victor Sage
30 Oct 2026
Merino & Co. entered FY2027 with A$1.404 million in cash after a A$1.010 million capital raising, giving the company more room to develop its botanical dye project and expand fulfilment. The stronger balance sheet came alongside a A$164,000 operating cash outflow and fully drawn NAB loan facilities.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive